Vestal Device

DEVICE3 trials

Sponsors

Neurovalens Ltd.

Conditions

Metabolic SyndromeObesityOverweightOverweight and ObesityOverweight or ObesityType 2 Diabetes

Unknown Phase

Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control as a Means of Reducing Excess Body Weight

CompletedNCT04110717

Neurovalens Ltd.Metabolic Syndrome, Obesity, Overweight +2

Start: 2020-10-09End: 2021-03-23Updated: 2023-04-03

Effect of VeSTAL Device in Type 2 Diabetes Mellitus

CompletedNCT04149951

Neurovalens Ltd.Metabolic Syndrome, Type 2 Diabetes

Start: 2020-06-03End: 2021-01-22Updated: 2024-01-16

Efficacy of Electrical Vestibular Nerve Stimulation (VeNS) in the Management of Obesity: A Randomized Clinical Trial

CompletedNCT05275790

Neurovalens Ltd.Obesity

Start: 2022-04-01End: 2022-10-17Updated: 2023-11-13